ABRJ(Neptunus Pharm)

N/A

Report date: 2023/06/28 20:00:26

Base Information

Drug NameABRJ(Neptunus Pharm)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Neptunus Pharmaceutical Research Institute Co LtdShenyang Pharmaceutical Dalei Yunshang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Neptunus Pharmaceutical Research Institute Co LtdShenyang Pharmaceutical Dalei Yunshang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A